Matches in Wikidata for { <http://www.wikidata.org/entity/Q91524033> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q91524033 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91524033 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91524033 description "scientific article published on 02 April 2020" @default.
- Q91524033 description "wetenschappelijk artikel" @default.
- Q91524033 description "наукова стаття, опублікована 2 квітня 2020" @default.
- Q91524033 name "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 name "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 type Item @default.
- Q91524033 label "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 label "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 prefLabel "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 prefLabel "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 P1433 Q91524033-FD90DA3B-9AB6-45B9-800B-3D06970B60B5 @default.
- Q91524033 P1476 Q91524033-AE5C133F-DF7E-4F41-9D80-487B615E20E3 @default.
- Q91524033 P2093 Q91524033-0F47D6EB-399B-4FE1-8BFF-449B6A4D816C @default.
- Q91524033 P2093 Q91524033-28BFD041-111F-4F0E-AB5B-38D31EFB4179 @default.
- Q91524033 P2093 Q91524033-3DD801DB-09BA-4BFC-B810-A58546D784BD @default.
- Q91524033 P2093 Q91524033-42DA51D7-7FC1-48A0-90B7-92223D686C5A @default.
- Q91524033 P2093 Q91524033-5C31DB05-E8CB-48B5-A80A-732320E2C470 @default.
- Q91524033 P2093 Q91524033-882C2795-650C-4E3A-9ED8-871A770A261D @default.
- Q91524033 P2093 Q91524033-E8B6A993-FC91-4B04-8577-3451AB09BCB2 @default.
- Q91524033 P304 Q91524033-5D5FCF35-7344-4C99-A761-06DFD261A9FF @default.
- Q91524033 P31 Q91524033-1711d0fe-00f0-46d4-a290-0727b766e672 @default.
- Q91524033 P31 Q91524033-E51F5442-A849-4566-8942-8333D503F4CF @default.
- Q91524033 P356 Q91524033-12C314EB-E7E2-45CA-BD6A-9974B45CE53F @default.
- Q91524033 P433 Q91524033-495B8269-1CAA-4BB2-9A44-406115E999DF @default.
- Q91524033 P478 Q91524033-293CE8DA-2AE5-4285-978C-4C642D0B9E34 @default.
- Q91524033 P577 Q91524033-F2F3449E-9C06-4D20-805F-E02D24D5933B @default.
- Q91524033 P698 Q91524033-DFDD49CE-A9E5-40DB-AF26-17477EE7CEC9 @default.
- Q91524033 P921 Q91524033-1DDD6B1A-986C-45E7-B8DE-E77E2E93C624 @default.
- Q91524033 P932 Q91524033-2FE8A6BA-E7D0-4422-A8F7-8F27E3881297 @default.
- Q91524033 P356 S40264-020-00926-3 @default.
- Q91524033 P698 32242310 @default.
- Q91524033 P1433 Q15724462 @default.
- Q91524033 P1476 "Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab" @default.
- Q91524033 P2093 "David J Jackson" @default.
- Q91524033 P2093 "James G Zangrilli" @default.
- Q91524033 P2093 "Peter Barker" @default.
- Q91524033 P2093 "Sameer K Mathur" @default.
- Q91524033 P2093 "Stephanie Korn" @default.
- Q91524033 P2093 "Ubaldo J Martin" @default.
- Q91524033 P2093 "Venkata G Meka" @default.
- Q91524033 P304 "409-425" @default.
- Q91524033 P31 Q13442814 @default.
- Q91524033 P31 Q7318358 @default.
- Q91524033 P356 "10.1007/S40264-020-00926-3" @default.
- Q91524033 P433 "5" @default.
- Q91524033 P478 "43" @default.
- Q91524033 P577 "2020-04-02T00:00:00Z" @default.
- Q91524033 P698 "32242310" @default.
- Q91524033 P921 Q35869 @default.
- Q91524033 P932 "7165132" @default.